ResMed | RMD - Trade Creditors

Stock Price
252.93
Daily Change
0.06 0.02%
Monthly
-4.03%
Yearly
6.89%
Q1 Forecast
245.23

ResMed reported $250.41M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Ansell USD 302.3M 51.4M Dec/2025
Artivion USD 16.5M 2.93M Sep/2025
AtriCure USD 78.4M 3.56M Dec/2025
Baxter International USD 999M 46M Dec/2025
Cochlear AUD 281.3M 17.1M Dec/2025
Cooper Companies USD 225.8M 74.6M Dec/2025
CSL USD 3.17B 290M Dec/2025
Dexcom USD 1.83B 1.38B Dec/2025
Edwards Lifesciences USD 165M 94.2M Sep/2025
Fisher Paykel Healthcare NZD 267.8M 4M Dec/2025
Globus Medical USD 98.85M 11.62M Dec/2025
Haemonetics USD 48.69M 13M Dec/2025
Hologic USD 201.1M 573.5M Dec/2025
Idexx Laboratories USD 110.41M 11.86M Dec/2025
Inogen USD 21.22M 684K Sep/2025
Insulet USD 75M 26.8M Dec/2025
Integra LifeSciences USD 95.73M 3.42M Dec/2025
Intuitive Surgical USD 1.92B 179.7M Dec/2025
Masimo USD 103M 14.9M Dec/2025
Medtronic USD 2.58B 26M Sep/2025
Philips EUR 1.93B 214M Dec/2025
Ramsay Health Care AUD 2.02B 289.9M Dec/2025
ResMed USD 250.41M 16.37M Dec/2025
Sigma Healthcare AUD 1.32B 970.03M Dec/2025
Sonic Healthcare AUD 313.54M 543.93M Jun/2024
Steris USD 285.1M 23.8M Dec/2025
Teleflex USD 130.2M 35.71M Dec/2025
Thermo Fisher Scientific USD 3.62B 502M Dec/2025